These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10673628)

  • 21. Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3.
    Vinatzer U; Gollinger M; Müllauer L; Raderer M; Chott A; Streubel B
    Clin Cancer Res; 2008 Oct; 14(20):6426-31. PubMed ID: 18927281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology. The paracaspase connection.
    Yu L; Lenardo MJ
    Science; 2003 Nov; 302(5650):1515-6. PubMed ID: 14645834
    [No Abstract]   [Full Text] [Related]  

  • 23. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
    Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
    Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. API2-MALT1 fusion gene in colorectal lymphoma.
    Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
    Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
    Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
    Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of malignant lymphoma: mantle cell lymphoma, anaplastic large cell lymphoma, and marginal zone B-cell lymphoma of malt.
    Shimoyama Y; Sakakibara A; Kawai K; Nagasaka T; Nakamura S
    Nagoya J Med Sci; 2006 Jan; 68(1-2):1-8. PubMed ID: 16579170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommendations for the cytogenetic management of adult malignant non-Hodgkin lymphoma proposed by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):260-2. PubMed ID: 15217709
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic alterations underlying the pathogenesis of MALT lymphoma.
    Bertoni F; Cavalli F; Cotter FE; Zucca E
    Hematol J; 2002; 3(1):10-3. PubMed ID: 11960389
    [No Abstract]   [Full Text] [Related]  

  • 30. CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas.
    Adam P; Haralambieva E; Greiner A; Ott M; Rosenwald A; Ott G
    Haematologica; 2006 Nov; 91(11):1575-6. PubMed ID: 17043017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
    Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
    J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mucosa-associated lymphoid tissue lymphoma].
    Gong LP; Zheng J; Gao ZF
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):240-3. PubMed ID: 16776985
    [No Abstract]   [Full Text] [Related]  

  • 33. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
    Morris SW; Kirstein MN; Valentine MB; Dittmer K; Shapiro DN; Look AT; Saltman DL
    Science; 1995 Jan; 267(5196):316-7. PubMed ID: 7824924
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytogenetics and molecular genetics of non-Hodgkin's lymphoma].
    Mazur G; Haus O
    Pol Arch Med Wewn; 2002 Oct; 108(4):993-1000. PubMed ID: 12642946
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell biology: divining cancer cell weaknesses.
    Kaelin WG
    Nature; 2006 May; 441(7089):32-4. PubMed ID: 16672958
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies Identify Non-Hodgkin Lymphoma Suppressor.
    Cancer Discov; 2015 Dec; 5(12):OF6. PubMed ID: 26463831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in aggressive lymphoma: the contribution of novel biological markers.
    Montserrat E
    Ann Hematol; 2001; 80 Suppl 3():B42-4. PubMed ID: 11757705
    [No Abstract]   [Full Text] [Related]  

  • 38. Individualized target therapy of malignant lymphomas: an outlook.
    Anagnostopoulos I
    Recent Results Cancer Res; 2007; 176():177-88. PubMed ID: 17607925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new genetics and non-Hodgkin lymphoma.
    Dyer MJ
    Eur J Cancer; 1990; 26(10):1099-102. PubMed ID: 2148886
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cytogenetics of malignant lymphomas in the year 2000].
    Quesnel B
    Bull Cancer; 2000 Jan; 87(1):25-7. PubMed ID: 10673628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.